Pyxis Oncology Inc (PYXS) stock news · rev $13.9M
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
This PYXS news page leads with what Pyxis Oncology Inc filed — not a scraped headline mill.
No cached 8-K sentence for PYXS yet. We will not pad this page with generic market recap.
Latest reported PYXS revenue for 2025-12-31 was $13.9M. Net income was -$79.6M. PYXS currently screens at market cap $109.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PYXS stock page; for the tape open the quote page.
PYXS stock news FAQ
What are PYXS's latest revenue and net income?
Latest cached Pyxis Oncology Inc (PYXS) revenue for Dec 31, 2025 was $13.9M. Net income was -$79.6M. Statements: https://lician.com/financials/pyxs
What is PYXS's market cap?
Pyxis Oncology Inc (PYXS) market cap is $109.6M on the latest cached fundamentals snapshot.
What kind of company is PYXS?
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Where is PYXS stock news listed?
Cached stock news for Pyxis Oncology Inc (PYXS) is listed at https://lician.com/news/pyxs. Filings: https://lician.com/sec/pyxs
Not investment advice.